OpenAlex
PricingAboutJobs
Log inGet started
Work

Sodium–glucose cotransporter-2 inhibitors and blood pressure decrease: a valuable effect of a novel antidiabetic class?

HTML

Year: 2015
Type: review
Source: Journal of Hypertension
DOI: 10.1097/hjh.0000000000000719
Authors: Konstantinos P. Imprialos, Pantelis A. Sarafidis, Asterios I. Karagiannis
Institutions: Aristotle University of Thessaloniki, Ippokrateio General Hospital of Thessaloniki
Language: English

Topic: Diabetes Treatment and Management
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Keywords: SGLT2 inhibitors, blood pressure reduction, type 2 diabetes, dapagliflozin, canagliflozin, empagliflozin, ipragliflozin, luseogliflozin, tofogliflozin, sodium excretion, diuretic effect, ambulatory blood pressure monitoring, antidiabetic drugs
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2398685869
FWCI: 0.968
Cites: 102
Cited by: 80
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security